⌘K

Login Start Free

Home/Filings/4/0001209191-21-038994

4//SEC Filing

Favet Michael 4

Accession 0001209191-21-038994

CIK 0001528287other

View on SEC.gov Company Profile

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 6:04 PM ET

Size

8.3 KB

Accession

0001209191-21-038994

Insider Transaction Report

Form 4

Period: 2021-06-04

NeuroPace IncNPCE

DirectorChief Executive Officer

Transactions

Award
Common Stock
2021-06-04+26,590→ 26,590 total
Award
Stock Option (Right to Buy)
2021-06-04+53,180→ 53,180 total
Exercise: $21.67From: 2021-06-04Exp: 2031-06-03→ Common Stock (53,180 underlying)

Holdings

Common Stock
(indirect: See Footnote)
22,947

Footnotes (3)

[F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on April 22, 2022 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.
[F2]Shares are held by the Favet Living Trust, of which the Reporting Person and the Reporting Person's spouse serve as co-trustees.
[F3]25% of the shares subject to the option vest on April 22, 2022. The remaining shares subject to the option vest in twelve (12) equal quarterly installments thereafter. The option is early exercisable.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NeuroPace Inc

CIK 0001528287

Entity typeother

Related Parties

1

filerCIK 0001855656

Filing Metadata

Form type: 4
Filed: Jun 7, 8:00 PM ET
Accepted: Jun 8, 6:04 PM ET
Size: 8.3 KB

View on SEC.gov